The Melanoma Research Alliance (MRA) anticipates supporting at least $12.8 million in new funding. Proposals will be accepted for Team Science, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Special Opportunities are also available in immunotherapy, women in research, and patient-centric clinical trials.
MRA encourages applications from a diverse pool of investigators. Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP
|•||October 6: Team Science Award Letters of Intent Due|
|•||November 3: Young Investigator Award Eligibility Checklist Due|
|•||November 17: Young Investigator and Pilot Awards Full Proposals Due|
|•||January 19: Team Science Award Full Proposals Due (from invited applicants)|
URL for more information:
All proposals are due by 11:59 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/.
Filed Under: Funding Opportunities